EX-21.1 3 a58258exv21w1.htm EX-21.1 exv21w1
Exhibit 21.1
Name of Subsidiary   Jurisdiction   Doing Business As
Avantome, Inc.   Delaware   Avantome, Inc.
Epicentre Technologies Corporation   Wisconsin   Epicentre Biotechnologies
Helixis, Inc.   Delaware   Helixis, Inc.
Illumina Australia Pty. Ltd.   Australia   Illumina Australia Pty. Ltd.
Illumina Brasil Produtos de
Biotecnologia Ltda.
  Brazil   Illumina Brazil
Illumina Cambridge, Ltd.   United Kingdom   Illumina Cambridge, Ltd.
Illumina Canada, Inc.   New Brunswick, Canada   Illumina Canada, Inc.
Illumina France Holding Sarl   France   Illumina France Holding Sarl
Illumina France Sarl   France   Illumina France Sarl
Illumina GmbH   Germany   Illumina GmbH
Illumina Hong Kong Limited   Hong Kong   Illumina Hong Kong Limited
Illumina Iceland ehf   Iceland   Illumina Iceland ehf
Illumina Italy S.r.l.   Italy   Illumina Italy S.r.l.
Illumina K.K.   Japan   Illumina K.K.
Illumina Netherlands B.V.   Netherlands   Illumina Netherlands B.V.
Illumina New Zealand Limited   New Zealand   Illumina New Zealand Limited
Illumina Singapore Pte. Ltd.   Singapore   Illumina Singapore Pte. Ltd
Illumina Trading (Shanghai) Co., Ltd.   China   Illumina Trading (Shanghai) Co., Ltd.
Illumina UK, Ltd.   United Kingdom   Illumina UK, Ltd.
Lynx Therapeutics GmbH   Germany   Lynx Therapeutics GmbH
**   All listed subsidiaries are wholly-owned, direct or indirect, subsidiaries of Illumina, Inc.
**   As permitted under Rule 601 of Regulation S-K, we have omitted the names of subsidiaries, which if considered in the aggregate as a single subsidiary, would not constitute a “significant subsidiary” (as defined in Rule 1-02(w) of Regulation S-X) as of the end of the year covered by this report